Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

CD-MPR Inhibitors

CD-MPR inhibitors constitute a distinctive chemical class renowned for their capacity to selectively modulate the activity of cation-dependent mannose-6-phosphate receptors (CD-MPRs). These receptors play a pivotal role in cellular processes associated with the intracellular trafficking of lysosomal enzymes. CD-MPRs are membrane proteins found in the trans-Golgi network, where they facilitate the sorting and transport of newly synthesized lysosomal enzymes by recognizing and binding to mannose-6-phosphate residues. The intricate mechanism involves the formation of a complex between CD-MPRs and lysosomal enzymes, allowing their transport to lysosomes for proper cellular degradation and recycling. Inhibition of CD-MPRs by specific chemical entities disrupts the normal trafficking of lysosomal enzymes, influencing the overall dynamics of intracellular protein degradation. CD-MPR inhibitors may act through competitive binding to the mannose-6-phosphate recognition site on the receptors, preventing the formation of the CD-MPR-enzyme complex crucial for proper lysosomal targeting. The modulation of CD-MPR activity by these inhibitors presents a unique avenue for researchers to delve into the intricacies of cellular trafficking pathways and the regulation of lysosomal function. Understanding the structural and biochemical aspects of CD-MPR inhibitors is fundamental to unraveling the complexities of intracellular protein sorting and degradation processes, contributing valuable insights to the broader field of cell biology.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

Chloroquine is a weak base that can increase the pH of acidic compartments like lysosomes, potentially affecting the pH-dependent binding of lysosomal enzymes to CD-MPR.

Bafilomycin A1

88899-55-2sc-201550
sc-201550A
sc-201550B
sc-201550C
100 µg
1 mg
5 mg
10 mg
$98.00
$255.00
$765.00
$1457.00
280
(6)

Bafilomycin A1 is an inhibitor of the V-ATPase that can increase lysosomal pH, potentially affecting the pH-dependent binding of lysosomal enzymes to CD-MPR.

Concanamycin A

80890-47-7sc-202111
sc-202111A
sc-202111B
sc-202111C
50 µg
200 µg
1 mg
5 mg
$66.00
$167.00
$673.00
$2601.00
109
(2)

Concanamycin A is another V-ATPase inhibitor that could potentially affect the pH-dependent binding of lysosomal enzymes to CD-MPR.